In advanced HCC, high levels of CLCF1 expression result in an augmented CLCF1-CXCL6/TGFβ pathway, recruiting more TANs and polarizing them toward the N2 phenotype to further facilitate tumor progression [15,69,71]. This evidence concerns the gene CXCL6 and hepatocellular carcinoma.